BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/19/2020 11:55:31 AM | Browse: 503 | Download: 1228
 |
Received |
|
2020-07-21 05:37 |
|
Peer-Review Started |
|
2020-07-21 05:37 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-09-30 03:23 |
|
Revised |
|
2020-10-13 14:20 |
|
Second Decision |
|
2020-10-28 10:03 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-11-02 04:46 |
|
Articles in Press |
|
2020-11-02 04:46 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-11-12 04:51 |
|
Typeset the Manuscript |
|
2020-12-15 12:24 |
|
Publish the Manuscript Online |
|
2020-12-19 11:55 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
Blockage of ETS homologous factor inhibits the proliferation and invasion of gastric cancer cells through the c-Met pathway
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Meng-Li Gu, Xin-Xin Zhou, Meng-Ting Ren, Ke-Da Shi, Mo-Sang Yu, Wen-Rui Jiao, Ya-Mei Wang, Wei-Xiang Zhong and Feng Ji |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The Traditional Chinese Medicine Science and Technology Plan of Zhejiang Province |
2017ZZ010 |
| Zhejiang Medical Science and Technology Program |
2018266817 |
|
| Corresponding Author |
Feng Ji, MD, PhD, Chief Doctor, Professor, Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China. jifeng@zju.edu.cn |
| Key Words |
Gastric cancer; ETS homologous factor; c-Met; Antineoplastic target; Signaling pathway; |
| Core Tip |
The purpose of this article is to investigate the role and mechanism of ETS homologous factor (EHF) in the occurrence and development of gastric cancer (GC). It was found that EHF plays a key role in cell proliferation, invasion, apoptosis, the cell cycle and epithelial-to-mesenchymal transition. EHF may contribute to the tumorigenesis and progression of GC via the c-Met pathway. Therefore, EHF is a promising target for the diagnosis and treatment of GC. |
| Publish Date |
2020-12-19 11:55 |
| Citation |
Gu ML, Zhou XX, Ren MT, Shi KD, Yu MS, Jiao WR, Wang YM, Zhong WX, Ji F. Blockage of ETS homologous factor inhibits the proliferation and invasion of gastric cancer cells through the c-Met pathway. World J Gastroenterol 2020; 26(47): 7497-7512 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i47/7497.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i47.7497 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
